Michel Perez

This inventor holds 24 USPTO granted patents and 9 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in Antibody-Drug Conjugates. Top assignee: Pierre Fabre Medicament. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Perez. Retrieved from https://idiyas.com/inventor/michel-perez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 9)

% Patents Active = 70.8

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 64(Granted Patents)

Company Filing History:

24 out of 269

Pierre Fabre Medicament

patents

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Antibody-Drug Conjugate

Sulfomaleimide Linkers

IGF-1R

Flavagline Derivatives

Cancer Treatment

Benzothiazines

Pyrazolo

Indole Derivatives

PAR-1 Antagonists

5-HT1B

5-HT1D

Medicaments

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12011485 - Sulfomaleimide-based linkers and corresponding conjugates (2024-06-18),

2. 11918656 - Antibody-drug-conjugate and its use for the treatment of cancer (2024-03-05),

3. 11661457 - IGF-1R antibody-drug-conjugate and its use for the treatment of cancer (2023-05-30),

4. 11517625 - Antibody-drug-conjugate and its use for the treatment of cancer (2022-12-06),

5. 11219693 - Antibody-drug-conjugate and its use for the treatment of cancer (2022-01-11),

6. 10912841 - Antibody-drug-conjugate and its use for the treatment of cancer (2021-02-09),

7. 10858423 - Composition for the treatment of IGF-1R expressing cancer (2020-12-08),

8. 10633448 - IGF-1R antibody-drug-conjugate and its use for the treatment of cancer (2020-04-28),

9. 10519125 - Flavagline derivatives (2019-12-31),

10. 10314921 - Antibody-drug-conjugate and its use for the treatment of cancer (2019-06-11),

11. 10047064 - Flavagline derivatives (2018-08-14),

12. 9669106 - Conjugate of monomethyl auristatin F and trastuzumab and its use for the treatment of cancer (2017-06-06),

13. 9416143 - Griseofulvin derivatives (2016-08-16),

14. 9187438 - Derivatives of benzothiazines, preparation thereof and application thereof as drugs (2015-11-17),

15. 8883821 - Substituted pyrazolo[3,4-b]pyridines as medicaments (2014-11-11),

Title: Inventor Michel Perez: Revolutionizing Technology in Castres

Introduction: Michel Perez, a visionary inventor hailing from Castres, France, has been at the forefront of technological advancements in his region.

Latest Patents: Perez's latest patents include groundbreaking innovations in renewable energy systems and sustainable transportation solutions, showcasing his commitment to environmental conservation.

Career Highlights: With a career spanning over two decades, Perez has established himself as a leading figure in the field of clean technology, with numerous awards recognizing his contributions to the industry.

Collaborations: Throughout his career, Perez has collaborated with top research institutions and universities in France, fostering a culture of innovation and knowledge-sharing in the scientific community.

Conclusion: Michel Perez's dedication to pushing the boundaries of technology and his passion for creating a more sustainable future make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.